Table 1.
Clinical indicators, targets, maximum thresholds, and points for achieving targets that directly affect chemical pathology laboratories
| Annex A code | Clinical indicator and target | Maximum threshold | Points |
| CHD 7 | The percentage of patients with CHD whose notes have a record of total cholesterol in the previous 15 months | 90% | 7 |
| CHD 8 | The percentage of patients with CHD whose last measured total cholesterol (measured in the last 15 months) is 5 mmol/l or less | 60% | 16 |
| Stroke 7 | The percentage of patients with TIA or stroke who have a record of total cholesterol in the past 15 months | 90% | 2 |
| Stroke 8 | The percentage of patients with TIA or stroke whose last measured total cholesterol (measured in the past 15 months) is 5 mmol/l or less | 60% | 5 |
| DM 5 | The percentage of patients with diabetes who have a record of HbA1C or equivalent in the past 15 months | 90% | 3 |
| DM 6 | The percentage of patients with diabetes in whom the last HbA1C was 7.4 or less in the past 15 months | 50% | 16 |
| DM 7 | The percentage of patients with diabetes in whom the last HbA1C was 10.0 or less in the past 15 months | 85% | 11 |
| DM 13 | The percentage of patients with diabetes who have a record of microalbuminuria testing in the past 15 months (exception, reporting for patients with proteinuria) | 90% | 3 |
| DM 14 | The percentage of patients with diabetes who have a record of serum creatinine testing in the past 15 months | 90% | 3 |
| DM 16 | The percentage of patients with diabetes who have a record of total cholesterol in the past 15 months | 90% | 3 |
| DM 17 | The percentage of patients with diabetes whose last measured total cholesterol within the past 15 months was 5 or less | 60% | 6 |
| Thyroid 2 | The percentage of patients with hypothyroidism with thyroid function tests recorded in the past 15 months | 90% | 6 |
| MH 3 | The percentage of patients on lithium treatment with a record of lithium concentrations checked within the past 6 months | 90% | 3 |
| MH 4 | The percentage of patients on lithium treatment with a record of serum creatinine and TSH in the preceding 15 months | 90% | 3 |
| MH 5 | The percentage of patients on lithium treatment with a record of lithium concentrations in the therapeutic range within the past 6 months | 70% | 5 |
CHD, coronary heart disease; HbA1C, glycated haemoglobin; TIA, transient ischaemic attack; TSH, thyroid stimulating hormone.